Regulatory Affairs for Biomaterials and Medical Devices
Series: Woodhead Publishing Series in Biomaterials;
- Publisher's listprice EUR 165.00
-
68 433 Ft (65 175 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 6 843 Ft off)
- Discounted price 61 590 Ft (58 658 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
68 433 Ft
Availability
cancelled
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 30 October 2018
- ISBN 9780081015339
- Binding Paperback
- No. of pages202 pages
- Size 229x152 mm
- Language English 0
Categories
Long description:
All biomaterials and medical devices are subject to a long list of regulatory practises and policies which must be adhered to in order to receive clearance. This book provides readers with information on the systems in place in the USA and the rest of the world. Chapters focus on a series of procedures and policies including topics such as commercialization, clinical development, general good practise manufacturing and post market surveillance.
MoreTable of Contents:
1. Biomaterials and their applications in medicine
I. Kulinets, Northeastern University, USA
2. Technical considerations for the commercialization of biomaterials
N. Scarborough, NLS Consulting, USA and N. Mukherjee, Covidien, USA
3. Regulatory strategies for biomaterials and medical devices in the USA: Classification, design and risk analysis
S. F. Amato, Northeastern University, USA
4. Clinical development and endpoint strategies for biomaterials and medical devices
S. F. Amato, Northeastern University, USA
5. The clinical evaluation and approval threshold of biomaterials and medical devices
K. G. Stevens, DePuy Synthes Spine, USA
6. Supply chain controls for biomaterials and medical devices in the USA
S. F. Amato, Northeastern University, USA
7. Global marketing authorisation of biomaterials and medical devices
J. J. Tobin, ChemHaz Solutions, Ireland
8. Good manufacturing practice (GMP) for biomaterials and medical devices in the EU and the USA
F. Tarabah, Strategiqual, France
9. Post market surveillance approaches for biomaterials and medical devices in the USA
K. Desai, Northeastern University, USA
10. Fundamentals of medical device approval in Asia
J. L. Wong, ARPA, Hong Kong and P. Teysseyre, Johnson & Johnson Medical Asia Pacific, Singapore
Regulatory Affairs for Biomaterials and Medical Devices
68 433 HUF
61 590 HUF
Cranes
2 810 HUF
2 585 HUF
The machine
2 810 HUF
2 585 HUF
Toulouse-Lautrec and Montmartre
16 721 HUF
15 049 HUF
The Few and the Cursed: Crows of Mana'olana
17 587 HUF
16 181 HUF
